These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 25668655)

  • 21. Two-year follow-up of cognitive functions in schizophrenia spectrum disorders of adolescent patients treated with electroconvulsive therapy.
    de la Serna E; Flamarique I; Castro-Fornieles J; Pons A; Puig O; Andrés-Perpiña S; Lázaro L; Garrido JM; Bernardo M; Baeza I
    J Child Adolesc Psychopharmacol; 2011 Dec; 21(6):611-9. PubMed ID: 22136098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuation electroconvulsive therapy for relapse prevention in middle-aged and elderly patients with intractable catatonic schizophrenia.
    Suzuki K; Awata S; Takano T; Ebina Y; Iwasaki H; Matsuoka H
    Psychiatry Clin Neurosci; 2005 Aug; 59(4):481-9. PubMed ID: 16048455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness and clinical predictors of response to combined ECT and antipsychotic therapy in patients with treatment-resistant schizophrenia and dominant negative symptoms.
    Pawełczyk T; Kołodziej-Kowalska E; Pawełczyk A; Rabe-Jabłońska J
    Psychiatry Res; 2014 Dec; 220(1-2):175-80. PubMed ID: 25129562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short-term effect of combined ECT and neuroleptic therapy in treatment-resistant schizophrenia.
    Chanpattana W; Chakrabhand ML; Kongsakon R; Techakasem P; Buppanharun W
    J ECT; 1999 Jun; 15(2):129-39. PubMed ID: 10378152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined use of ECT with aripiprazole.
    Lopez-Garcia P; Chiclana C; Gonzalez R
    World J Biol Psychiatry; 2009; 10(4 Pt 3):942-3. PubMed ID: 17853257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of electroconvulsive therapy combined with antipsychotic medication in treatment-resistant schizophrenia: a prospective, open trial.
    Tang WK; Ungvari GS
    J ECT; 2002 Jun; 18(2):90-4. PubMed ID: 12195137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Executive attention deficits in schizophrenia: putative mandatory and differential cognitive pathology domains in medicated schizophrenia patients.
    Meiron O; Hermesh H; Katz N; Weizman A
    Psychiatry Res; 2013 Aug; 209(1):1-8. PubMed ID: 23102537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Selective alteration of the declarative memory systems in patients treated with a high number of electroconvulsive therapy sessions].
    Rami-González L; Boget-Llucià T; Bernardo M; Marcos T; Cañizares-Alejos S; Penadés R; Portella MJ; Castelví M; Raspall T; Salamero M
    Rev Neurol; 2002 Nov 1-15; 35(9):805-8. PubMed ID: 12436375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short- and long-term neurocognitive functioning after electroconvulsive therapy in depressed elderly: a prospective naturalistic study.
    Verwijk E; Comijs HC; Kok RM; Spaans HP; Tielkes CE; Scherder EJ; Stek ML
    Int Psychogeriatr; 2014 Feb; 26(2):315-24. PubMed ID: 24280446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maintenance ECT in treatment-resistant schizophrenia.
    Chanpattana W
    J Med Assoc Thai; 2000 Jun; 83(6):657-62. PubMed ID: 10932493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of maintenance electroconvulsive therapy (M-ECT) in treatment-resistant schizophrenia: A case series.
    Purohith AN; Chatorikar SA; Praharaj SK; Bhandary RP; Sharma PSVN
    Asian J Psychiatr; 2022 Jul; 73():103132. PubMed ID: 35533602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuation ECT in treatment-resistant schizophrenia: a controlled study.
    Chanpattana W; Chakrabhand ML; Sackeim HA; Kitaroonchai W; Kongsakon R; Techakasem P; Buppanharun W; Tuntirungsee Y; Kirdcharoen N
    J ECT; 1999 Sep; 15(3):178-92. PubMed ID: 10492856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The augmentation of clozapine treatment with electroconvulsive therapy.
    Gazdag G; Kocsis-Ficzere N; Tolna J
    Ideggyogy Sz; 2006 Jul; 59(7-8):261-7. PubMed ID: 17076304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Electroconvulsive therapy and schizophrenia. Update from the data of the literature].
    Joober R; Bennegadi Z; Olié JP; Lôo H
    Encephale; 1991; 17(4):267-72. PubMed ID: 1683628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ketamine Anesthesia, Efficacy of Electroconvulsive Therapy, and Cognitive Functions in Treatment-Resistant Depression.
    Rybakowski JK; Bodnar A; Krzywotulski M; Chlopocka-Wozniak M; Michalak M; Rosada-Kurasinska J; Bartkowska-Sniatkowska A
    J ECT; 2016 Sep; 32(3):164-8. PubMed ID: 27008330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rivastigmine treatment for the prevention of electroconvulsive therapy-induced memory deficits in patients with schizophrenia.
    Stryjer R; Ophir D; Bar F; Spivak B; Weizman A; Strous RD
    Clin Neuropharmacol; 2012; 35(4):161-4. PubMed ID: 22751086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized comparison of ultra-brief bifrontal and unilateral electroconvulsive therapy for major depression: cognitive side-effects.
    Sienaert P; Vansteelandt K; Demyttenaere K; Peuskens J
    J Affect Disord; 2010 Apr; 122(1-2):60-7. PubMed ID: 19577808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of Electroconvulsive Therapy and Associated Cognitive Change in Schizophrenia: A Naturalistic, Comparative Study of Treating Schizophrenia With Electroconvulsive Therapy.
    Tor PC; Ying J; Ho NF; Wang M; Martin D; Ang CP; Tan C; Yap LS; Lu VJM; Simpson B; Mok YM; Loo C
    J ECT; 2017 Dec; 33(4):272-277. PubMed ID: 28640170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concurrent administration of clozapine and ECT: a successful therapeutic strategy for a patient with treatment-resistant schizophrenia.
    Bhatia SC; Bhatia SK; Gupta S
    J ECT; 1998 Dec; 14(4):280-3. PubMed ID: 9871852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive impairment of executive function as a core symptom of schizophrenia.
    Wobrock T; Ecker UK; Scherk H; Schneider-Axmann T; Falkai P; Gruber O
    World J Biol Psychiatry; 2009; 10(4 Pt 2):442-51. PubMed ID: 18609418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.